Research and Markets Cardiac Marker Diagnostic Tests Markets Examined



May 6, 2005 -- Research and Markets (http://www.researchandmarkets.com/reports/c16884) has announced the addition of Cardiac Marker Diagnostic Tests Markets to their offering.

The purpose of this report is to present an overview of the diagnostic testing cardiac marker market with the latest information regarding emerging new products and industry trends. It will not only quantify but also qualify, for you, the cardiac marker market marker segments as an area of research, product development and investment. Forecasts of the cardiac marker market and an analysis of products in the worldwide diagnostics market will provide a basis for understanding the significance of past developments and future possibilities within this diagnostic category.

The principle objectives of this report are to:
- Identify viable technology drivers through a comprehensive look at various platform technologies for cardiac marker segments of the diagnostic testing markets;
- Obtain a complete understanding of the chief cardiac markers and their diagnostic test predictive, screening, prognostic, monitoring, pharmacogenomic, and theranostic value, understanding these elements from their basic principles to their applications;
- Discover feasible market opportunities via an identification of high-growth applications in different cardiac marker diagnostic testing areas, with a focus on the biggest and fastest expanding markets for diseases;
- Focus on global industry development through an in-depth analysis of the major world markets for cardiac marker diagnostic testing, including forecasts for growth; and
- Present market figures regarding the current value of the cardiac marker testing market, projections and growth rates. These are taken from the most recently available data of the global diagnostic industry. Projections and forecasts for the future of the diabetes market ranges to 2010.

Companies profiled include:
Abbott Laboratories
Ani Biotech
Axis-Shield
Bayer Corporation
Beckman-Coulter
Biosite, Inc.
Dade Behring
Diagnostic Products Corp
Inverness Medical Innovations
International Medical Innovations
Johnson & Johnson
LifeSign
Randox Laboratories
Response Biomedical
Roche Diagnostics
Sierra Resources International
Spectral Diagnostics, Inc.
SYN X Pharm

For more information visit http://www.researchandmarkets.com/reports/c16884

Laura Wood
Senior Manager
Research and Markets
e-mail protected from spam bots
Fax: +353 1 4100 980





Research and Markets Cardiac Marker Diagnostic Tests Markets Examined